Kistler-Tiffany Companies’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $32.5K | Hold |
322
| – | – | 0.01% | 546 |
|
|
2023
Q1 | $29.6K | Buy |
322
+1
| +0.3% | +$87 | 0.01% | 497 |
|
|
2022
Q4 | $29.1K | Hold |
321
| – | – | 0.01% | 486 |
|
|
2022
Q3 | $24K | Hold |
321
| – | – | 0.01% | 466 |
|
|
2022
Q2 | $27K | Hold |
321
| – | – | 0.01% | 459 |
|
|
2022
Q1 | $28K | Buy |
321
+2
| +0.6% | +$173 | 0.01% | 465 |
|
|
2021
Q4 | $28K | Hold |
319
| – | – | 0.01% | 448 |
|
|
2021
Q3 | $26K | Hold |
319
| – | – | 0.01% | 456 |
|
|
2021
Q2 | $29K | Hold |
319
| – | – | 0.01% | 436 |
|
|
2021
Q1 | $27K | Buy |
319
+89
| +39% | +$7.99K | 0.01% | 415 |
|
|
2020
Q4 | $22K | Hold |
230
| – | – | 0.01% | 408 |
|
|
2020
Q3 | $20K | Hold |
230
| – | – | 0.01% | 389 |
|
|
2020
Q2 | $20K | Buy |
230
+1
| +0.4% | +$86 | 0.01% | 362 |
|
|
2020
Q1 | $22K | Hold |
229
| – | – | 0.01% | 349 |
|
|
2019
Q4 | $22K | Hold |
229
| – | – | 0.01% | 356 |
|
|
2019
Q3 | $20K | Sell |
229
-18
| -7% | -$1.62K | 0.01% | 365 |
|
|
2019
Q2 | $23K | Buy |
247
+177
| +253% | +$15K | 0.01% | 339 |
|
|
2019
Q1 | $6K | Buy |
70
+1
| +1% | +$80 | ﹤0.01% | 488 |
|
|
2018
Q4 | $5K | Hold |
69
| – | – | ﹤0.01% | 481 |
|
|
2018
Q3 | $5K | Hold |
69
| – | – | ﹤0.01% | 497 |
|
|
2018
Q2 | $5K | Buy |
69
+2
| +3% | +$138 | ﹤0.01% | 483 |
|
|
2018
Q1 | $5K | Hold |
67
| – | – | ﹤0.01% | 497 |
|
|
2017
Q4 | $5K | Hold |
67
| – | – | ﹤0.01% | 474 |
|
|
2017
Q3 | $5K | Hold |
67
| – | – | ﹤0.01% | 454 |
|
|
2017
Q2 | $5K | Sell |
67
-283
| -81% | -$20.1K | ﹤0.01% | 439 |
|
|
2017
Q1 | $23K | Sell |
350
-72
| -17% | -$4.8K | 0.01% | 330 |
|
|
2016
Q4 | $28K | Hold |
422
| – | – | 0.01% | 316 |
|
|
2016
Q3 | $30K | Sell |
422
-9
| -2% | -$656 | 0.01% | 318 |
|
|
2016
Q2 | $32K | Sell |
431
-897
| -68% | -$62K | 0.02% | 309 |
|
|
2016
Q1 | $86K | Hold |
1,328
| – | – | 0.05% | 197 |
|
|
2015
Q4 | $102K | Hold |
1,328
| – | – | 0.06% | 194 |
|
|
2015
Q3 | $109K | Hold |
1,328
| – | – | 0.07% | 178 |
|
|
2015
Q2 | $117K | Buy |
1,328
+7
| +0.5% | +$642 | 0.07% | 172 |
|
|
2015
Q1 | $117K | Buy |
1,321
+313
| +31% | +$27.8K | 0.07% | 159 |
|
|
2014
Q4 | $84K | Hold |
1,008
| – | – | 0.05% | 186 |
|
|
2014
Q3 | $85K | Sell |
1,008
-2
| -0.2% | -$162 | 0.06% | 191 |
|
|
2014
Q2 | $82K | Hold |
1,010
| – | – | 0.06% | 181 |
|
|
2014
Q1 | $77K | Sell |
1,010
-491
| -33% | -$35.8K | 0.06% | 185 |
|
|
2013
Q4 | $108K | Sell |
1,501
-754
| -33% | -$52.4K | 0.08% | 155 |
|
|
2013
Q3 | $155K | Buy |
2,255
+558
| +33% | +$36.9K | 0.13% | 109 |
|
|
2013
Q2 | $108K | Buy |
+1,697
| New | +$110K | 0.09% | 138 |
|
Other funds holding NVS
Kistler-Tiffany Companies's NVS Position: Q2 2023 in Review
Kistler-Tiffany Companies held its Novartis (NVS) position steady in Q2 2023 at 322 shares worth $32.5K. The position accounts for 0.01% of the portfolio, ranked #546.
Kistler-Tiffany Companies first reported a position in NVS in Q2 2013 and has held it in 41 quarters since. The position peaked at $155K in Q3 2013. 1,203 funds tracked by Wall St. Rank hold NVS as of Q2 2023.
- Kistler-Tiffany Companies held 322 shares of Novartis worth $32.5K as of Q2 2023.
- Kistler-Tiffany Companies left its Novartis share count unchanged in Q2 2023.
- Novartis made up 0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #546 holding.
- Kistler-Tiffany Companies first reported a position in Novartis in Q2 2013 and has held it in 41 quarters since.
- Kistler-Tiffany Companies's Novartis position peaked at $155K in Q3 2013.
- 1,203 funds tracked by Wall St. Rank held Novartis as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.